CHONDROITINASE, METHOD OF ITS PREPARING AND PHARMACEUTICAL COMPOSITION CONTAINING THEREOF Russian patent published in 2000 - IPC

Abstract RU 2144833 C1

FIELD: biotechnology, medicine, biochemistry. SUBSTANCE: invention relates to enzyme chondroitinase used in chemical-pharmaceutical industry, highly purified chondroitinase and the method of enzyme preparing and pharmaceutical compositions containing this enzyme. Invention relates to enzyme chondroitinase ABC from Proteus vulgaris cells, its molecular mass is 100 000 Da, isoelectric point is 8.3-8.5, enzyme has alanine as N-terminal amino acid and proline as C-terminal amino acid. Method of preparing involves extraction of cells of indicated microorganism, removal of nucleic acids and chromatography using strong and weak cation-exchange resins. Purified enzyme chondroitinase ABC is needle-like and prismatic crystals of the definite crystalline lattice. Pharmaceutical compositions has the purified enzyme in combination with additionally added nonionic surface-active substance and stabilizing agents. EFFECT: increased purity degree and stability of enzyme preparation. 20 cl, 20 tbl, 12 dwg, 14 ex

Similar patents RU2144833C1

Title Year Author Number
DERMATAN SULFATE OR ITS SALT, ANTITHROMBOTIC AGENTS, METHOD OF PROPHYLAXIS AND TREATMENT OF THROMBOSIS, METHOD OF PROPHYLAXIS OR TREATMENT OF DISSEMINATED INTRAVASCULAR COAGULATION SYNDROME, METHOD OF MYOCARDIUM INFARCTION TREATMENT 1994
  • Akikazu Takada
  • Dzjuniti Onaja
  • Mikio Arai
  • Satosi Mijauti
  • Mamoru Kiogasima
  • Kejiti Esida
RU2153506C2
PHOTOCONSOLIDATED DERIVATIVE OF GLYCOSEAMINOGLYCAN, CROSS- -LINKED DERIVATIVE OF GLYCOSEAMINOGLYCAN AND METHODS OF THEIR SYNTHESIS, COMPOSITION FOR MEDICINAL USE, METHOD OF PREVENTION OF CELLULAR AND TISSUE ADHESION 1993
  • Takekhisa Matsuda
  • Minoo Dzh.Mogkhaddam
  • Katsukijo Sakurai
RU2139886C1
PHARMACEUTICAL COMPOSITION INCLUDING ENZYME CLEAVING GLYCOSAMINOGLYCANS AND USE INDICATED ENZYME FOR PREPARING MEDICINAL PREPARATION FOR THERAPY OF HERNIA OF INTERVERTEBRAL DISK 1998
  • Nokhara Jutaka
  • Isikava Khiroki
RU2209080C2
PACKAGING AND METHOD OF ITS OBTAINING 2019
  • Higuchi, Mine
RU2798169C2
PHARMACEUTICAL COMPOSITION, PACKAGING AND METHOD FOR ITS OBTAINING 2019
  • Higuchi, Mine
RU2788173C2
POLYPEPTIDES OR THEIR SALTS AND PHARMACEUTICAL COMPOSITION 1992
  • Nobutaka Fudzii[Jp]
  • Naoki Jamamoto[Jp]
  • Akiesi Matsumoto[Jp]
  • Mitinori Vaki[Jp]
RU2083589C1
FRACTION OF KERATANSULFATE OLIGOSACCHARIDES AND PHARMACEUTICAL PREPARATION CONTAINING THEREOF 1995
  • Marujama Khirosi
  • Morikava Kijosi
  • Tavada Akira
  • Mijauti Satosi
  • Josida Kejiti
  • Asari Akira
RU2173154C2
SUCCINIC ACID DERIVATIVES, SUCCINIC ACID-POLYSACCHARIDE DERIVATIVE, METHOD OF PREPARING SUCCINIC ACID-GLYCOSAMINOGLYCANE DERIVATIVE, METHOD OF PREPARING SUCCINIC ACID-POLYAMINOSACCHARIDE DERIVATIVE, AND METHOD OF PREPARING CROSS- LINKED SUCCINIC ACID-POLYSACCHARIDE DERIVATIVE 1995
  • Mitinori Vaki
  • Kendzi Mijamoto
  • Josikhiro Motani
RU2169136C2
METHOD FOR PURIFICATION OF RECOMBINANT TUMOR NECROSIS FACTOR 0
  • Yuniti Kadzikhara
  • Takao Kieta
  • Khirosi Khayasi
SU1630602A3
THERAPEUTIC HERNIA OF INTERVERTEBRAL DISK 2011
  • Sirogane Tajiti
  • Murayama Takao
  • Yaguti Masafumi
RU2690185C2

RU 2 144 833 C1

Authors

Nobukazu Khasimoto

Khideo Motizuki

Akio Khamai

Siniti Isikava

Misako Torikai

Isao Mijati

Dates

2000-01-27Published

1993-06-25Filed